Publications

Impact of Regulatory Risk Communication on Thrombosis With Thrombocytopenia Syndrome for Covid-19 Adenovirus Vector Vaccines on European Healthcare Professionals

AuthID
P-017-H3P

Author(s)

van Vliet, E

Lipovec, NČ

van der Goot, M

Abtahi, S

Ribeiro Vaz, I

Poplavska, E

Dermiki Gkana, F

Oikonomou, C

Deligianni, E

Kontogiorgis, C

Silva, AM

Ferreira, PBS

Kos, M

Almarsdóttir, AB

Jacobsen, R

Buhl, C

de Bruijn, A

Hegger, I

Alves, TL

Document Type

Article

Year published

2024

Published

in Pharmacoepidemiology and Drug Safety, ISSN: 1053-8569

Volume: 33, Issue: 12

Indexing

Scopus^®

Crossref^®

Pubmed^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.1002/pds.70057

Pubmed: 39586738

Scopus: 2-s2.0-85210103790

Source Identifiers

ISSN: 1053-8569

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

Impact of Regulatory Risk Communication on Thrombosis With Thrombocytopenia Syndrome for Covid-19 Adenovirus Vector Vaccines on European Healthcare Professionals

Useful Links

Get Help

Federated Authentication (Click on the image)

Impact of Regulatory Risk Communication on Thrombosis With Thrombocytopenia Syndrome for Covid-19 Adenovirus Vector Vaccines on European Healthcare Professionals

Useful Links

Get Help